1. Dysregulation of the Hippo pathway signaling in aging and cancer
   Yiu To Yeung et al, 2019, Pharmacological Research CrossRef
2. Deacetylation of YAP1 Promotes the Resistance to Chemo- and Targeted Therapy in FLT3-ITD+ AML Cells
   Panpan Feng et al, 2022, Frontiers in Cell and Developmental Biology CrossRef
3. Oncogenic USP22 supports gastric cancer growth and metastasis by activating c-Myc/NAMPT/SIRT1-dependent FOXO1 and YAP signaling
   Hongxia Liu et al, 2019, Aging CrossRef
4. Obesity‐mediated upregulation of the YAP/IL33 signaling axis promotes aggressiveness and induces an immunosuppressive tumor microenvironment in breast cancer
   Jia‐Zih Dai et al, 2023, Journal of Cellular Physiology CrossRef
5. Dysfunctional Mechanotransduction through the YAP/TAZ/Hippo Pathway as a Feature of Chronic Disease
   Mathias Cobbaut et al, 2020, Cells CrossRef
6. Inhibition of visfatin alleviates sepsis-induced intestinal damage by inhibiting Hippo signaling pathway
   Zhong-Shen Kuang et al, 2022, Inflammation Research CrossRef
7. Adiponectin in Gastrointestinal Malignancies
   Batoul Farran et al, 2020, Novel therapeutic approaches for gastrointestinal malignancies CrossRef